期刊文献+

两个新的前列腺癌相关分泌蛋白的鉴定和表达

Identification and expression of two new secretory proteins associated with prostate cancer
下载PDF
导出
摘要 为了获得代表不同前列腺癌进展阶段的细胞系的胞外蛋白表达谱,验证其中差异表达蛋白是否为分泌蛋白,在细胞水平看其是否有作为前列腺癌血清标志物的潜质,文章利用双向电泳寻找胞外蛋白中差异表达的点,并质谱鉴定其是何种蛋白质。应用RT-PCR方法分析候选分子在8种细胞系中的表达和对雄激素刺激的应答,构建了候选分子的真核表达载体,瞬时转染293T细胞,应用标签抗体Western blotting方法检测验证细胞培养基中候选分子的表达。结果表明:筛选出两个C4-2胞外高表达的分子--磷酸丙糖异构酶-1(Triosephosphate isomerase1,TPI1)和多配体聚糖结合蛋白(Syndecan binding protein,syntenin,ST1);转录水平发现它们与前列腺癌恶性程度相关,并且后者受雄激素的作用下调;二者均为分泌蛋白。磷酸丙糖异构酶-1和多配体聚糖结合蛋白均有作为指示前列腺癌发展阶段的血清标志物的潜质。 Our research intends to obtain extra-cellular proteinogram of cell lines representing different advancement stages of prostate cancer and to test whether screened differential expression proteins can be secreted and used as serum biomarkers for prostate cancer.By examining differential expression spots in two extra-cellular protein 2D-PAGE gels and mass spectrum,candidate molecules were obtained.The expressions of these candidate molecules in eight cell lines and response to androgen stimulus in LNCaP were analyzed by RT-PCR.By constructing eukaryotic expression vectors and western-blotting with anti tags antibodies,the candidate molecules were tested to understand whether they can be expressed in tansfected 293T cell culture fluid.Two overexpressed molecules-triosephosphate isomerase 1 (TPI1) and syndecan binding protein,syntenin (ST1)-in extra-cellular proteinogram of C4-2 were screened out;both of them are secretary proteins.On transcriptional level,both proteins were up-regulated with the malignancy of prostate cancer cell lines and ST1 was dose-dependently inhibited by androgen.Considering cellular level results,both TPI1 and ST1 have their potential as serum biomarkers for indicating the developmental stage of prostate cancer.
出处 《遗传》 CAS CSCD 北大核心 2010年第3期235-241,共7页 Hereditas(Beijing)
基金 国家高技术研究发展计划项目(编号:2008AA02Z123) 国家自然科学基金项目(编号:30770834 30870961)资助
关键词 前列腺癌 血清标志物 分泌蛋白 磷酸丙糖异构酶-1 多配体聚糖结合蛋白 prostate cancer serum biomarkers secretary proteins TPI1 ST1
  • 相关文献

参考文献15

  • 1Jemal A,Siegel R,Samuels A,Ward E,Hao YP Xu JQ,Murray T,Thun MJ.Cancer statistics,2008.CA Cancer J Clin,2008,58(1):71-96.
  • 2Liu GF.Epidemiologieal survey of benign prostatic byperplasia and prostate cancer in China.Chin Med J,2000,113(4):299-302.
  • 3Thalmann GN,Sikes RA,Wu TT,Degeorges A,Chang SM,Ozen M,Pathak S,Chung LWK.LNCaP Progression model of human prostate cancer:androgen-independence and osseous metastasis.Prostate,2000,44(2):91-103.
  • 4Volmer MW,Radacz Y,Hahn SA,Klein-Scory S,Stuhler K,Zapatka M,Schmiegel W,Meyer HE,Schwarte-Waldhoff I.Tumor suppressor Smad4 mediates downregulation of the anti-adhesive invasion promoting matricellular protein SPARC:Landscaping activity of Smad4 as revealed by a "secretome" analysis.Proteomics,2004,4(5):1324-1334.
  • 5甄朱.蛋白质组学进展[J].生物工程学报,2001,17(5):491-493. 被引量:40
  • 6吴松锋,朱云平,贺福初.人类蛋白质组表达谱蛋白质鉴定的分步搜索策略[J].遗传,2005,27(5):687-693. 被引量:5
  • 7Sardana G,Marshall J,Diamandis EP.Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture-conditioned medium.Clin Chem,2007,53(3):429-437.
  • 8Martin DB,Gifford DR,Wright ME,Keller A,Yi E,Goodlett DR,Aebersold R,Nelson PS.Quantitative proteomic analysis of proteins released by neoplastic prostate epithelium.Cancer Res,2004,64(1):347-355.
  • 9Katayama M,Nakano H,Ishiuehi A,Wu WW,Oshima R,Sakurai J,Nishikawa H,Yamaguchi S,Otsubo T.Protein pattern difference in the colon cancer cell lines examined by two-dimensional differential in-gel electrophoresis and mass spectrometry.Surg Today,2006,36(12):1085-1093.
  • 10Chen GA,Gharib TG,Huang CC,Thomas DG,Shedden K.A,Taylor JMG,Kardia SLR,Misek DE,Giordano TJ,Iannettoni MD,Orringer MB,Hanash SM,Beer DG.Proteomic analysis of lung adenocarcinoma:identification of a highly expressed set of proteins in tumors.Clin Cancer Res,2002,8(7):2298-2305.

二级参考文献12

  • 1Jain K K,Pharmacogenomics,2000年,1卷,4期,385页
  • 2Perkins D N, Pappin D J, Creasy D M, Cottrell J S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis, 1999, 20 (18) :3551-3567.
  • 3Liska A J, Shevchenko A. Expanding the organismal scope of proteornics:cross-species protein identification by mass spectrometry and its implications. Proteornics, 2003, 3(1),19-28.
  • 4International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature, 2001, 409(6822) : 860-921.
  • 5Mouse Genome Sequencing Consortium. Initial sequencing and comparative analysis of the mouse genome. Nature, 2002, 420(6915) : 520-562.
  • 6Kersey P J, Duarte J, Williams A, Karavidopoulou Y, Birney E,Apweiler R. The International Protein Index, an integrated data-base for proteomics experiments. Proteomics. 2004, 4(7):1985-1988.
  • 7Galperin M Y. The Molecular Biology Database Collection:2004 update. Nucleic Acids Res, 2004, 32: Database issue:D3-22.
  • 8Imanishi T et al. Integrative annotation of 21 037 human genes validated by full-length cDNA clones. Plos Biol, 2004, 2 : 856-875.
  • 9Kristiansen T Z, Bunkenborg J, Gronborg M, Molina H, Thuluvath P J, Argani P, Goggins M G, Maitra A, Pandey A. A proteomic analysis of human bile. Mol Cell Proteomics, 2004, 3(7): 715-728.
  • 10俞利荣,曾嵘,夏其昌.蛋白质组研究技术及其进展[J].生命的化学,1998,18(6):4-9. 被引量:41

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部